Personalized medicine powered by data-driven insights is a monumental shift that delivers better prevention, diagnosis, and treatment at a fraction of the time and cost. We will look at some of the global disruptions that are driving the need for change and the technologies that are emerging to propel the market forward. This represents a significant opportunity for EMBS to partner with HIMSS to help steer the innovations, establish standards, and help drive this transformation.
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Precision medicine is being fueled by data that is not only big, but also deep. To tackle some of the most vexing problems in cancer, big data is being generated on deep molecular levels. For the individual tumor, measurements of the genome, epigenome, transcriptome, proteome and metabolome are being coupled with traditional clinical data. Facing us are data-driven challenges, such as: how does this multiscale data advance our knowledge of cancer biology and how can we use it to improve patient outcomes? While deep learning approaches tackle these types of questions often without domain-specific knowledge, systems biology has emerged as a field to address these questions by embracing domain-specific knowledge. The field of cancer systems biology unites the data scientist and molecular biologist toward a common goal of identifying clinically actionable insights from a better understanding of cancer biology by harnessing big and deep data across multiple scales.
This presentation will illustrate the principles of cancer systems biology with examples that aim to harness big and deep data to advance precision medicine in cancer.
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As Professor of Radiology and Biomedical Data Science at Stanford University, Sylvia Plevritis leads an integrative cancer research program that bridges genomics, proteomics, imaging and population sciences. On the molecular level, her lab is both "dry" and "wet": it develops biocomputational algorithms to infer regulatory networks underlying tumor progression and conducts bench work on tumor samples for optimizing combination therapy. On the population level, her lab develops simulation models of clinical cancer progression to estimate the effectiveness of alternative cancer control strategies on incidence and mortality rates. With the advancement of mobile devices and wireless sensing, mobile health (mHealth) platforms have become increasingly useful tools to reduce healthcare costs and improve quality of life. mHealth systems provide the unique opportunity to automatically collect data from individuals in the community or hospital to provide healthcare providers with meaningful information about their behaviors and support health behavior change. Wireless data about an individual's physiological and environmental state can elucidate their symptoms, skills practice, and behaviors. Through real-time feedback, individuals can be notified of insufficient management of their health and correct the behaviors before they become set in their daily lives.
Leadership Experience
In this talk we will review a mhealth infrastructure and discuss several trials that have been using this infrastructure. These trials are in the area of mental health, sports analytics, and congestive heart failure among others. We will also discuss novel analytics methodologies such as opportunistic learning and group based learning. 
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The global healthcare system is due for a massive upgrade that will improve population health outcomes, reduce overall costs, and increase patient and provider experiences. This will likely be fueled by innovations in ultra low power portable or implantable sensors and devices for digital phenotyping, molecular technologies that allow us to explore and understand the structure and function of our bodies in ways previously unimaginable, as well as big and deep data infrastructure and the associated analytics tools that will help us make sense of it all.
We have our eyes on the promised land of personalized, precise, predictive, and preventive healthcare, and it is extremely exciting. That said, there exists a reasonably large chasm between the world of technological innovation and translation into healthcare practice. This presentation will highlight some of our ongoing work at Microsoft, as a technology company trying to contribute to the evolving healthcare landscape, and discuss observations we have made as we navigate this. Smart healthcare is gradually shifting its focus from symptomatic diagnostics and therapy to disease prevention and asymptomatic disease interception. While disease prevention mainly focuses on stimulating (healthy) behavior and behavior change, disease interception implies capturing a disease before the first symptoms occur and developing therapies applicable in such an early stage of the disease process. It is expected that both prevention and disease interception will need personal digital phenotyping -the use of digital and wearable technology to track health parameters and behavior over an extended period of time so as to identify risk factors and triggers.
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This presentation will give an overview of imec innovations in the field of patient management, prevention and disease interception, combining hardware innovations and analytics innovations.
At imec, wearable health R&D has focused on developing highly-comfortable, medical-grade wireless solutions for the diagnosis and management of cardiovascular, neurological and cardiopulmonary disorders. We also create systemon-chip solutions that combine a wide range of on-chip electrophysiological sensor readouts with sensor fusion, powerful signal processing, memory, power management, connectivity. While providing accurate diagnosis and efficient treatment tools addresses an important need for the foreseeable future, we have set up an R&D program on prevention and disease interception which we term 'imec.ichange'. In this R&D activity, digital phenotyping is one of the key ingredients.
To achieve a lasting behavior change, we need to go beyond motivation and focus on people's personal ability to change by providing personal triggers. This can be accomplished by accurately, unobtrusively and securely tracking a wider range of physiological parameters and by gathering contextual information on our behavior, habits, schedule, location, activity, etc. Combining detailed physiological data and detailed contextual data makes it possible to create an individual digital phenotype. This digital phenotype can then be used to give highly-personalized feedback and suggestions when you are open to act on them. Compared to the generic advice now provided by wearables, this kind of personal feedback provided at the right time is a true paradigm shift.
A specific example concerns mental stress management. Over the past 2 years, we have carried out a largescale study where we did measured physiological stress signals, and enriched these with self-reported stress information and smartphone based contextual information. Wearable technology has made it possixxxv ble to detect stress outside of the lab, in a real-life context. However, it also comes with new challenges in terms of data quality.
At the end of this road, our vision is to truly quantify what it means to live a healthy lifestyle and how diseases can be intercepted. It may very well take a decade or a generation to get there, but achieving this goal will have a health impact beyond our wildest dreams.
Chris Van Hoof -Senior Director of Wearable Health Solutions, imec fellow and Professor at KU Leuven.
Chris Van Hoof leads imec's wearable health R&D across 3 imec sites (Eindhoven, Leuven and Gent). Imec's wearable health teams provide solutions for chronic-disease patient monitoring and for preventive health through virtual coaching. Chris has taken wearable health from embryonic research to a business line serving international customers.
Chris likes to make things that really work and apart from delivering industry-relevant qualified solutions to customers, his work resulted in 5 imec startups (4 in the healthcare domain). After receiving a PhD from the KU Leuven in 1992 in collaboration with imec, Chris has held positions as manager and director in diverse fields (sensors, imagers, 3D integration, MEMS, energy harvesting, body area networks, biomedical electronics, wearable health). He has published over 600 papers in journals and conference proceedings and has given more than 80 invited talks. He is a full professor at KU Leuven.
